A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
N Engl J Med
.
2020 Jul 9;383(2):e8.
doi: 10.1056/NEJMc2017351.
Authors
Anne-Céline Martin
1
,
David M Smadja
2
,
Nicole Karam
3
Affiliations
1
European Hospital Georges Pompidou, Paris, France
[email protected]
.
2
INSERM UMR-S 1140, Paris, France.
3
University of Paris, Paris, France.
PMID:
32640141
DOI:
10.1056/NEJMc2017351
No abstract available
Publication types
Letter
Comment
MeSH terms
Aortic Valve Stenosis / surgery*
Heart Valve Prosthesis*
Humans
Rivaroxaban
Transcatheter Aortic Valve Replacement*
Substances
Rivaroxaban